Symptomdx.

Get Started

Anastomotic leak and post-operative intra-abdominal abscessMANAGEMENT

GASTROINTESTINAL PRESENTATIONS · 12 SECTIONS

⚲

757 items

☷ Legend

01Approach to the Critical Patient/attcp75

Recognition triggers

›The returning post-operative patient

›Post-operative day 5-10 is the peak declaration window

›Median time to clinical leak diagnosis is day 7

›Presentation after apparent uneventful recovery is typical, not atypical

›Presentation after hospital discharge is common

›Working rule

›A post-operative patient not progressing as expected has an anastomotic leak until proven otherwise

›Failure to thrive on the ward is a leak equivalent, not a benign finding

›Non-specific early signs precede peritonitis

›New tachycardia out of proportion to pain

›New-onset atrial fibrillation

›Ileus that fails to resolve by post-operative day 4-5

›Unexplained deterioration without a localizing sign

Immediate priorities

›Sepsis and hemodynamic threats

›Sepsis screening in the post-operative patient

›Suspected intra-abdominal source with organ dysfunction

›Lactate >= 2 mmol/l

›Septic shock indicators

›SBP < 90 mmHg

›MAP < 65 mmHg

›New tachyarrhythmia with cold extremities

›If septic shock, follow institutional sepsis bundle without delay

›Broad-spectrum IV antibiotics within 1 hour

›See Treatment for anastomotic-leak-specific antibiotic selection

›Peritonitis and generalized contamination threats

›Free leak indicators

›Diffuse rigidity or board-like abdomen

›Guarding across all quadrants

›Extraluminal air or free fluid on imaging out of proportion to expected post-operative findings

›If diffuse peritonitis, emergent surgical consultation

›Do not delay for imaging when peritonitis is diffuse and the patient is unstable

›Resuscitate simultaneously with surgical notification

›Contained collection threats

›Localized tenderness or palpable mass

›Contained abscess concern

›Persistent fever or leukocytosis without diffuse peritonism

›CT abdomen and pelvis with oral and rectal contrast as first-line imaging

›See Diagnostic Tests for protocol and limitations

Monitoring and targets

›Monitoring bundle

›Continuous cardiac monitoring when hemodynamically unstable or tachycardic

›New atrial fibrillation evaluation

›Rate control does not substitute for source identification

›Urine output monitoring

›Target >= 0.5 ml/kg/hour

›Foley catheter for accurate monitoring in sepsis

›Serial abdominal reassessment

›Every 4-6 hours in the first 24 hours of concern

›Worsening guarding or rigidity triggers immediate surgical reassessment

›Drain output and character monitoring where a drain is present

›Change from serous to feculent, bilious, or purulent output

›Sudden increase in output volume

›Vasopressor titration monitoring

›Norepinephrine infusion

›MAP reassessment every 5-15 minutes during titration

›Reassess for mesenteric hypoperfusion risk at escalating doses

›Escalation triggers

›Failure to improve within 48-72 hours of source control attempt

›Repeat CT and re-evaluation for a step up in therapy

›See Treatment for the therapy-not-working pathway

›Hemodynamic deterioration despite resuscitation

›ICU-level care

›Vasopressor initiation

Immediate consults

›Consultation triggers

›Operating surgeon or on-call surgical team

›Notify for any suspected leak regardless of severity

›Emergent for diffuse peritonitis or hemodynamic instability

›Urgent for contained abscess or treatment failure

›Interventional radiology

›Accessible collection amenable to percutaneous drainage

›Coordinate timing with surgical team before drain placement

›ICU team

›Septic shock or vasopressor requirement

›Anticipated reoperation and post-operative monitoring need

›Gastroenterology or advanced endoscopy

›Endoscopic vacuum therapy or stent candidacy for esophageal or rectal leaks

02History/hx71

Timing and presentation pattern

›Core timing pattern

›Onset typically post-operative day 5-10

›Earlier onset (day 1-3) suggests technical failure or missed injury

›Later onset (after day 10, including post-discharge) still occurs and is often underestimated

›Interval of apparent wellbeing before decline

›Patient often tolerating diet and mobilizing before symptoms begin

›Family or patient report of "doing fine until yesterday"

›Presentation after discharge

›Readmission with fever, pain, or wound drainage

›Delayed presentation associated with higher complication rate at diagnosis

›Symptom pattern

›Vague or diffuse abdominal pain

›May be milder than expected for the degree of contamination

›Shoulder tip pain suggests diaphragmatic irritation from subphrenic collection

›Return of ileus after initial return of bowel function

›Nausea, vomiting, obstipation recurring

›Distension increasing rather than resolving

›Constitutional symptoms

›Malaise, anorexia, rigors

›Confusion or delirium, especially in older adults

Risk factors

›Anastomosis-specific risk

›Low rectal anastomosis

›Highest leak risk of colorectal anastomoses

›Risk increases as anastomotic height from the anal verge decreases

›Esophageal or esophagogastric anastomosis

›Tenuous blood supply at the gastric conduit tip

03Physical Exam/exam50

Vitals and general

›Hemodynamic assessment

›Heart rate

›Sustained tachycardia above the patient's post-operative baseline

›New atrial fibrillation as an early sepsis marker

›Blood pressure

›SBP < 90 mmHg as septic shock threshold

›Narrowing pulse pressure as an early sign

›Temperature

›Fever >= 38.5 C typical

›Absent fever does not exclude a leak, particularly with steroid use

›Respiratory rate

›Tachypnea from sepsis or from splinting due to abdominal pain

Abdominal and wound exam

›Localized findings

›Focal tenderness at the anastomotic site

›May be mild relative to underlying contamination

›Palpable mass

›Contained abscess or phlegmon

›Abdominal distension

›Recurrent ileus pattern

›Tense distension raises concern for intra-abdominal hypertension

›Peritoneal findings

›Voluntary guarding

›Localized contained process

›Involuntary rigidity

›Free leak with generalized peritonitis

›Rebound tenderness

04Differential Diagnosis/ddx51

Life threats and close mimics

›Surgical emergencies

›Anastomotic leak with generalized peritonitis

›ICD-10 K91.83 (complications of internal anastomosis, not elsewhere classified)

›Diffuse peritoneal signs, extraluminal contrast or air on CT

›Anastomotic leak with contained abscess

›ICD-10 K91.83 with a discrete collection on imaging

›Localized findings without diffuse peritonism

›Post-operative intra-abdominal abscess without a demonstrated leak

›ICD-10 K65.1 (peritoneal abscess)

›May represent a sealed microperforation not seen on imaging

›Mesenteric ischemia at the anastomosis

›ICD-10 K55.0

›Pain out of proportion, rising lactate

›Cardiopulmonary mimics

›Pulmonary embolism

›ICD-10 I26.99

›Post-operative hypercoagulable state, new tachycardia or atrial fibrillation overlaps with leak presentation

›New atrial fibrillation from a non-septic cause

›Post-operative fluid shifts or electrolyte derangement

›Still warrants a source evaluation before attribution

›Aspiration pneumonia

›ICD-10 J69.0

›Fever and tachycardia without abdominal findings

›Non-surgical infectious mimics

›Clostridioides difficile colitis

›ICD-10 A04.7

›Post-operative antibiotic exposure, diarrhea rather than ileus

05Laboratory Tests/lt61

Core infection and inflammatory labs

›Complete blood count

›Leukocytosis

›WBC > 12 x 10^9/L in the post-operative patient beyond the expected surgical stress window

›Left shift supports evolving bacterial infection

›Leukopenia as a severe sepsis marker

›Especially in immunosuppressed or steroid-treated patients

›Inflammatory markers

›C-reactive protein

›CRP > 150 mg/L on post-operative day 3-5 has been associated with anastomotic leak in colorectal surgery cohorts

›Trend more informative than a single value given expected post-operative elevation

›Procalcitonin

›Adjunctive for bacterial infection confirmation

›Rises with surgical stress alone, so interpret alongside the clinical trajectory

›Interpretation traps

›Expected post-operative leukocytosis and CRP elevation

›A normal or falling CRP trajectory is reassuring; a rising or plateauing trend after post-operative day 3 is not

›Blunted inflammatory response in steroid-treated or immunosuppressed patients

›Normal WBC and CRP do not exclude a leak in this group

›Anchor on the clinical trajectory and imaging rather than normal inflammatory markers

›Blood cultures

›Obtain before antibiotics when feasible

›Polymicrobial or enteric organism growth supports an intra-abdominal source

Drain fluid and fistula analysis

›Drain fluid amylase

›Elevated drain fluid amylase supports enteric or pancreatic content

›Markedly elevated levels relative to serum amylase support a leak

›A single value is supportive, not diagnostic; correlate with drain fluid appearance and clinical course

06Diagnostic Tests/dt67

Scoring Systems

›International Study Group of Rectal Cancer (ISREC) anastomotic leak grading

›Grade A

›Subclinical leak identified on imaging or during routine drain assessment

›No change in clinical management required

›Grade B

›Requires active therapeutic intervention without reoperation

›Antibiotics with or without percutaneous or transanal drainage

›Grade C

›Requires reoperation

›Associated with the highest morbidity and mortality of the three grades

›Clavien-Dindo classification of surgical complications

›Grade I-II

›No intervention or pharmacologic treatment only

›Grade III

›Requires a procedural, endoscopic, or surgical intervention

›Grade IV

›Life-threatening complication requiring ICU-level organ support

›Grade V

›Death of the patient

›Role in this topic

›Used to communicate complication severity between surgical teams, not a diagnostic tool

MRI

›MRI pelvis role

›Primary indication

›Suspected perianastomotic or perianal fistula tract when CT is indeterminate

›Pregnancy when CT is relatively contraindicated

›Imaging characteristics

›Fistula tract visualization with fat-suppressed sequences

›Collection wall characterization

›Limitations in the acute setting

›Longer acquisition time

›Limited availability after hours

›Not the initial test for the acutely unstable patient

›CT abdomen and pelvis with oral and rectal contrast

›First-line imaging for suspected anastomotic leak or intra-abdominal abscess

›Sensitivity for anastomotic leak is imperfect; a small or sealed leak can be radiologically occult

›Rectal contrast increases sensitivity for distal colorectal anastomotic leaks compared with oral contrast alone

›Key CT findings

›Extraluminal contrast extravasation at the anastomosis

›Extraluminal air beyond the expected early post-operative window

›Discrete peri-anastomotic fluid collection

›Fat stranding around the anastomotic site

›Limitations

›Post-operative free air and fluid are expected in the first 7-10 days and can mimic or mask a leak

›A negative CT does not exclude a leak when clinical suspicion is high

›Repeat imaging or operative exploration warranted if deterioration continues despite a negative study

›Abscess characterization on CT

›Size in maximum diameter

›Proximity to bowel and accessibility for percutaneous drainage

›Loculation pattern

›Contrast protocol considerations

›Water-soluble oral and rectal contrast, not barium, given the risk of ongoing leak

›IV contrast for collection wall enhancement and vascular assessment when mesenteric ischemia is a concern

Ultrasound

›Abdominal ultrasound role

›Alternative when CT is unavailable, contraindicated, or contrast delay is unacceptable

›Pregnancy as a primary indication

›Operator-dependent sensitivity limitation, reduced by post-operative dressings, ileus, and bowel gas

›Ultrasound findings

›Discrete hypoechoic or complex fluid collection

›Free fluid in the peritoneal cavity

›Guided procedures

›Ultrasound-guided percutaneous drainage for superficial or accessible collections

›CT guidance preferred for deep or complex pelvic collections

›Point-of-care ultrasound adjuncts

›Free fluid assessment in the unstable patient

›Not a substitute for CT in the stable patient

›Volume status assessment

›IVC collapsibility to guide fluid responsiveness alongside clinical exam

07Disposition/dispo50

Admission and ICU criteria

›Admission required for

›Any confirmed or strongly suspected anastomotic leak

›Any post-operative intra-abdominal abscess

›IV antibiotics required

›Drainage planning

›ICU indications

›Septic shock

›Vasopressor requirement

›Lactate >= 4 mmol/l

›Hemodynamic instability despite initial resuscitation

›SBP < 90 mmHg unresponsive to initial fluid bolus

›Peri-operative and post-reoperative monitoring requirement

›After emergent or urgent reoperation

Surgical and interventional radiology consultation

›Criteria favoring nonoperative management with drainage

›Contained, well-localized collection on imaging

›Hemodynamically stable patient

›No diffuse peritonitis on exam

›Collection accessible for percutaneous or endoscopic drainage

›Criteria favoring emergent reoperation

›Diffuse peritonitis or generalized contamination on imaging

›Hemodynamic instability not responding to resuscitation

›Clinical deterioration despite antibiotics and attempted drainage

›Collection not amenable to percutaneous or endoscopic access

›Timing principle

›Delay in source control is the dominant modifiable driver of mortality in this condition

›Every hour of delay in the unstable patient increases risk

08Treatment/t167

Initial stabilization

›Resuscitation priorities

›IV fluid resuscitation

›0.9% normal saline or lactated Ringer's, 30 ml/kg for sepsis

›Reassess fluid responsiveness after the initial bolus rather than continuing fixed-volume resuscitation

›NPO and bowel rest

›Acute phase management pending surgical or interventional decision

›Vasopressors if refractory hypotension

›Norepinephrine 0.01-0.5 mcg/kg/minute as first-line vasopressor

›Target MAP >= 65 mmHg

›See Iatrogenic harm review for mesenteric perfusion considerations

›Cross-reference

›Full sepsis resuscitation bundle, antimicrobial timing targets, and shock management follow the institutional sepsis pathway

›Not duplicated here; this section addresses considerations specific to a post-operative intra-abdominal source

Antibiotic regimens

›Empiric coverage, clinically stable patient

›Ceftriaxone plus metronidazole

›Ceftriaxone 1-2 g IV every 24 hours

›Metronidazole 500 mg IV every 8 hours

›Ertapenem monotherapy alternative

›1 g IV every 24 hours

›Empiric coverage, clinically unstable, severe, or recently hospitalized patient

›Piperacillin-tazobactam

›3.375-4.5 g IV every 6-8 hours

›Covers gram-negative enteric organisms and anaerobes, and healthcare-associated pathogens

›Meropenem

›1 g IV every 8 hours

›Reserved for severe sepsis, prior resistant organism, or recent broad-spectrum exposure

›Add empiric antifungal coverage for recurrent leak, prolonged prior antibiotic exposure, or growth of yeast from a culture

›Fluconazole 400 mg IV or PO daily as initial choice

›Escalate to an echinocandin if critically ill or fluconazole-resistant Candida is suspected

›Antibiotic duration and transition

›Duration guided by adequacy of source control, typically 4-7 days after effective drainage or reoperation

›Longer courses do not compensate for inadequate source control

›Transition to oral therapy when afebrile, tolerating enteral intake, and WBC trending down

›Oral step-down options

›Amoxicillin-clavulanate 875/125 mg PO every 12 hours

›Ciprofloxacin 500 mg PO every 12 hours plus metronidazole 500 mg PO every 8 hours

Source control: drainage and endoscopic management

›Percutaneous drainage for a contained collection

›Indications

›Discrete, accessible collection in a hemodynamically stable patient

›First-line when the leak is contained and the patient is not septic-shocked

›Procedure details

›CT or ultrasound guided

›Transabdominal, transgluteal, or transrectal approach depending on location

›Drain management

›Irrigate as directed by the placing service

›Remove when output is minimal and imaging confirms resolution

›Endoscopic options for accessible anastomoses (esophageal, gastric, or low rectal)

›Endoscopic vacuum therapy

›Sponge placed at the leak site under endoscopic guidance, connected to continuous negative pressure

›Sponge changed approximately every 3-5 days until granulation closes the defect

›Self-expanding stent

›Bridges a contained leak while inflammation resolves

›Best for early, contained defects without frank generalized contamination

›Endoscopic clipping

›Best for small, early defects

›Less established for larger or chronic anastomotic dehiscence

›Transanal drainage or washout for low rectal anastomotic leaks

›Local drainage of the presacral space

›Often combined with proximal fecal diversion rather than used alone for larger defects

Surgical reoperation and diversion

›Indications for reoperation

›Diffuse peritonitis or generalized contamination

›Hemodynamic instability unresponsive to resuscitation

›Failure of percutaneous or endoscopic source control

›Collection not accessible by percutaneous or endoscopic means

›Operative options

›Washout and wide drainage with proximal fecal or enteric diversion

›Loop ileostomy or colostomy for colorectal anastomotic leaks

›Preserves the anastomosis when tissue viability is adequate

›Takedown of the anastomosis with end stoma formation

›Hartmann-type procedure for a nonviable or grossly disrupted colorectal anastomosis

›Esophageal or esophagogastric leak reoperation

›Primary repair with wide mediastinal or pleural drainage if tissue is viable

›Esophageal diversion or exclusion reserved for extensive necrosis or failed repair

›Source control timing

›Delay in adequate source control is the strongest modifiable driver of mortality in this condition

›Do not defer reoperation for additional imaging in the unstable, diffusely peritonitic patient

Therapy-not-working troubleshooting

›Reassessment triggers after an initial source control attempt

›No clinical improvement within 48-72 hours of antibiotics with or without percutaneous drainage

›Repeat CT to reassess collection size, new loculation, or a new collection

›Escalate to surgical or interventional radiology re-evaluation rather than continuing the same regimen unchanged

›Rising or plateauing inflammatory markers after 48-72 hours

›Treatment failure pattern

›Reassess drain position and patency if a percutaneous drain is in place

›Recurrent fever after an initial afebrile interval

›New or missed collection

›Consider pylephlebitis if bacteremia persists without a demonstrable new collection

Iatrogenic harm review

›Intubation

›Aspiration risk from ileus, gastric distension, and a full stomach

›Rapid sequence induction with attention to gastric decompression when feasible

›Positive-pressure ventilation may worsen intra-abdominal hypertension in a tensely distended abdomen

›Sedation

›Standard induction doses of propofol or etomidate may precipitate hypotension in an already vasoplegic septic patient

›Reduce induction doses and pre-treat hypotension risk in septic shock

›Fluid loading

›Aggressive crystalloid resuscitation can worsen bowel wall and anastomotic edema

›Excess volume resuscitation is associated with intra-abdominal hypertension and abdominal compartment syndrome, which can further compromise anastomotic perfusion

›Reassess fluid responsiveness after the initial bolus rather than continuing fixed-volume boluses

›Oxygen

›Routine supplemental oxygen is not harmful but hyperoxia should be avoided once targets are met

›Titrate to a standard SpO2 target rather than empiric high-flow oxygen in a stable patient

›Vasopressors

›Norepinephrine and other vasopressors cause splanchnic and mesenteric vasoconstriction

›Can worsen bowel and anastomotic perfusion in a patient whose anastomosis is already ischemia-prone

›Use the lowest effective dose to meet the MAP target rather than over-titrating

›Mechanical circulatory support, including intra-aortic balloon pump

›Not indicated in this condition

›The hemodynamic picture is distributive from intra-abdominal sepsis, not primary cardiac pump failure

›Mechanical circulatory support does not address the underlying source and delays definitive source control

›Anticoagulation

›Therapeutic anticoagulation is generally held pending the surgical or interventional source-control decision

›Sepsis-induced coagulopathy and planned procedures both increase bleeding risk

›Pharmacologic VTE prophylaxis is often deferred immediately before a planned procedure and resumed once hemostasis is confirmed

›Discuss timing with the surgical or interventional team rather than defaulting to routine prophylaxis timing

›Fibrinolysis

›Not indicated for this condition

›No thrombotic process is being treated; fibrinolysis in this setting would worsen bleeding risk without benefit

›Analgesia

›Opioid analgesia can mask evolving peritonism and delay recognition of a leak

›The specific danger is a delayed diagnosis of diffuse peritonitis leading to delayed source control and death from uncontrolled sepsis

›Reassess the abdominal exam independent of reported pain control

›Opioids also worsen the ileus that is itself a leak warning sign

›Multimodal analgesia to minimize opioid dose where feasible

Nutritional support

›Nutritional route selection

›Enteral nutrition preferred when the gastrointestinal tract distal or proximal to the leak can be safely used

›Post-pyloric or distal feeding access bypassing the leak site when anatomically feasible

›Total parenteral nutrition when enteral access is not achievable or bowel rest is mandated

›Central line required

›Catheter-related infection monitoring

›Refeeding syndrome precautions

›Baseline phosphate, potassium, and magnesium before initiating nutritional support in a malnourished patient

›Malnutrition is itself a leak risk factor, increasing overlap with refeeding risk

›Start nutrition at a conservative caloric rate and advance gradually in at-risk patients

›Daily electrolyte monitoring during the first several days of feeding

›Hypophosphatemia and hypokalemia from refeeding can precipitate arrhythmia

›Obtain an ECG if refeeding-associated electrolyte shifts are significant

›Nutritional targets

›Protein-forward nutrition to support anastomotic and wound healing

›Dietitian involvement for caloric and protein target-setting in the prolonged post-operative course

Enterocutaneous fistula management

›Recognition

›Enteric content, feculent odor, or bile-stained fluid draining from the wound or drain site

›Confirms a persistent communication between bowel and skin

›Initial management principles

›Skin protection around the fistula site

›Ostomy appliance or wound management system to control effluent and protect surrounding skin

›Sepsis and source control take priority over fistula closure

›Drain any associated undrained collection before addressing the fistula itself

›Nutritional optimization

›High-output fistulas markedly increase fluid, electrolyte, and protein losses

›See Nutritional support for route selection and monitoring

›Expectant management principle

›Many enterocutaneous fistulas close spontaneously with sepsis control, nutritional optimization, and time

›Definitive operative closure, when required, is typically deferred for weeks to months to allow inflammation to resolve

Analgesic and supportive care

›Pain management

›Acetaminophen 1 g IV or PO every 6 hours

›First-line analgesic

›Maximum 4 g per 24 hours; reduce maximum daily dose in hepatic impairment

›Opioid use when needed

›Use the lowest effective dose given the risk of masking peritonism and worsening ileus

›See Iatrogenic harm review for the specific danger of opioid-masked deterioration

›NSAID avoidance

›Associated with anastomotic leak risk in some surgical cohorts

›Avoid in the setting of suspected or confirmed leak

›Antiemetic and supportive therapy

›Ondansetron 4-8 mg IV every 8 hours as needed

›First-line for post-operative nausea

›Nasogastric decompression for symptomatic ileus or obstruction

›Placed under direct vision or with imaging confirmation given altered post-operative anatomy

09Special Populations/sp57

Pregnancy

›Pregnancy-specific considerations

›Anastomotic leak in pregnancy is rare and follows prior abdominal or bowel surgery

›Anatomic displacement of the bowel by the gravid uterus may alter pain location

›Imaging approach

›Ultrasound first-line to minimize fetal radiation

›MRI without gadolinium as second-line

›CT with abdominal shielding if MRI is unavailable and the result is decision-critical; missed diagnosis is more dangerous than the radiation dose

›Antibiotic safety in pregnancy

›Ceftriaxone is Category B and preferred

›Metronidazole generally avoided in the first trimester

›Piperacillin-tazobactam Category B and acceptable

›Avoid fluoroquinolones

›Surgical and interventional risk in pregnancy

›Obstetric team co-management mandatory

›Fetal monitoring when gestational age >= 24 weeks

›Percutaneous drainage preferred over reoperation when the collection is accessible and the patient is stable

Geriatric

›Geriatric-specific presentations

›Atypical presentation common

›Afebrile infection in a substantial proportion of older adults despite significant contamination

›Delirium or new confusion as the presenting symptom

›Blunted WBC and CRP response

›Comorbidity burden

›Anticoagulation complicates drainage and reoperation planning

›Renal impairment affects antibiotic dosing and contrast use

›Cardiac disease affects fluid resuscitation volume and tolerance of new atrial fibrillation

›Higher mortality and complication risk

›Age > 75 years is an independent predictor of worse outcomes after anastomotic leak

›Frailty assessment to guide reoperation candidacy and goals-of-care discussion

›Disposition threshold

›Low threshold for admission and early surgical consultation given blunted clinical signs

Pediatrics

›Pediatric anastomotic leak features

›Uncommon overall; occurs after bowel resection for necrotizing enterocolitis, Hirschsprung disease pull-through, or trauma

›Presentation pattern parallels adults: recurrent ileus, new tachycardia, and unexplained deterioration after an initial recovery

›Imaging

›Ultrasound first to minimize radiation

›CT with water-soluble oral and rectal contrast reserved for diagnostic uncertainty after ultrasound

›Antibiotic dosing if needed

›Piperacillin-tazobactam 100 mg/kg of the piperacillin component IV every 8 hours, maximum adult dose applies

›Verify against current pediatric guideline before use

›Metronidazole 30 mg/kg/day IV divided every 8 hours, maximum 1.5 g/day

›Verify against current pediatric guideline before use

›Nutritional considerations

›Aggressive caloric and protein targets for growth needs

›Neonates and infants tolerate fluid and electrolyte derangement from a high-output fistula poorly and require closer monitoring than older children

›Glucose monitoring

›Neonates and infants have low glycogen reserve and become hypoglycemic quickly during prolonged NPO status or sepsis

›Point-of-care glucose checks at closer intervals than in adults

Immunosuppressed and corticosteroid-treated patients

›Blunted presentation

›Attenuated fever, leukocytosis, and peritoneal signs despite advanced contamination

›Applies to chronic corticosteroid use, solid organ transplant recipients, and active chemotherapy

›Practical implication

›A reassuring exam or normal inflammatory markers should not delay imaging when the clinical trajectory is abnormal

›Maintain a lower threshold for CT and for surgical consultation in this group

›Management modifications

›Broader empiric antimicrobial coverage considered earlier given higher risk of atypical or resistant organisms

›Corticosteroid stress dosing coordination with the treating service when applicable

›Lower threshold for early surgical involvement given the risk of rapid deterioration once signs finally appear

10Background/b55

Epidemiology

›Incidence by anastomosis site

›Colorectal anastomotic leak

›Roughly 3-6% overall, rising to roughly 10-15% for low rectal anastomoses

›Esophagectomy anastomotic leak

›Roughly 10-15% of esophagectomy patients

›Small bowel and ileocolic anastomotic leak

›Roughly 2-3%, generally lower than colorectal anastomoses

›Mortality and outcomes

›Colorectal anastomotic leak mortality

›Roughly 6-22% depending on severity grade and speed of source control

›Esophageal anastomotic leak mortality

›Among the highest of gastrointestinal anastomoses, roughly 2-3 times the mortality of patients without a leak

›Timing of source control as the dominant modifier

›Delayed reoperation beyond the point of hemodynamic decompensation substantially increases mortality

›Consequences and long-term burden

›Enterocutaneous fistula

›Develops in a minority of leaks managed with drainage or reoperation

›Permanent stoma rate

›Higher after emergent reoperation for a leak than after the original elective operation

›Prolonged hospital stay

›Anastomotic leak roughly doubles expected length of stay compared with an uncomplicated course

Pathophysiology

›Mechanism of anastomotic failure

›Local ischemia at the anastomotic line

›Watershed perfusion zones, particularly at the splenic flexure and low rectum

›Tension from inadequate mobilization

›Technical factors

›Stapler misfire or malalignment

›Contaminated field at the time of anastomosis

›Host healing factors

›Malnutrition, corticosteroids, radiotherapy, and smoking each independently impair collagen deposition and microvascular healing at the anastomosis

›Progression from microperforation to clinical leak

›Contained microleak

›Walled off by adjacent bowel, omentum, or mesentery

›May remain subclinical (ISREC Grade A) or progress to a discrete abscess

›Progression to abscess

›Localized collection with systemic inflammatory response but no free peritoneal contamination

›Progression to free leak and diffuse peritonitis

›Loss of containment, often precipitated by increased intraluminal pressure from ileus or distension

›Rapid clinical deterioration once containment fails

›Timeline correlate

›The day 5-10 declaration window reflects the time required for a microleak to either heal, wall off into a clinically apparent abscess, or break free of containment

›Explains why the patient often appears to be recovering normally before decline

Therapeutic Considerations

›Source control as the central principle

›The management ladder is organized around containment status, not leak size alone

›Antibiotics alone for a subclinical, walled-off microleak

›Percutaneous or endoscopic drainage for a contained, accessible collection

›Reoperation with diversion for diffuse contamination or an inaccessible source

›Speed of source control, not choice of antibiotic, is the primary determinant of survival in the unstable patient

›Sepsis management principle

›General sepsis resuscitation and antimicrobial timing follow the standard institutional sepsis pathway

›This topic adds source-control decision-making specific to a post-operative anastomosis and does not restate the general sepsis bundle

›Diversion versus primary repair decision-making

›Proximal diversion preserves the anastomosis when the bowel is viable and contamination is controlled

›Anastomotic takedown is favored when the tissue itself is nonviable or repair would be unreliable

›Individualized decision incorporating physiologic reserve, degree of contamination, and anastomosis location

11Patient Discharge Instructions/pdi29

copy discharge instructions

›Home care instructions

›Complete the entire antibiotic course exactly as prescribed

›Do not stop early even if feeling better

›Diet progression

›Follow the diet stage advanced by your surgical team

›Advance slowly and stop advancing if pain, nausea, or distension increase

›Activity

›Gradual return to normal activity over 1-2 weeks

›Avoid heavy lifting over 10 pounds for 2-4 weeks or as directed by your surgeon

›Avoid NSAIDs unless specifically approved by your surgical team

›Use acetaminophen for pain relief instead

›If a drain or fistula appliance is in place

›Keep the drain or appliance site clean and dry

›Record daily output volume and character

›Follow drain or ostomy care instructions provided at discharge

›Return to emergency department immediately for

›Fever above 38.5 C (101.3 F) or shaking chills

›Worsening abdominal pain or pain becoming generalized

›Increasing abdominal distension or inability to pass gas or stool

›Inability to tolerate oral fluids or medications

›New enteric, feculent, or foul-smelling drainage from the wound or drain site

›Drain falls out, stops draining suddenly, or output changes color dramatically

›Signs of infection at the drain or wound site: redness, swelling, warmth, or pus

›New or worsening rapid heartbeat, palpitations, dizziness, or fainting

›Mandatory follow-up appointments

›Surgical follow-up within 1-2 weeks of discharge

›Interventional radiology follow-up if a percutaneous drain remains in place

12References/r24

Guidelines and key sources

›Primary guidelines

›World Society of Emergency Surgery (WSES) guidelines on complicated intra-abdominal infections

›Sartelli M et al. World Journal of Emergency Surgery

›Source control principles and antimicrobial selection for intra-abdominal sepsis

›American Society of Colon and Rectal Surgeons (ASCRS) clinical practice guidelines for colon and rectal surgery

›Anastomotic leak recognition and management ladder for colorectal anastomoses

›International Study Group of Rectal Cancer consensus definition and grading of anastomotic leak

›Rahbari NN et al. Surgery 2010

›Grade A/B/C classification adopted widely for rectal and colorectal anastomotic leak

›Surviving Sepsis Campaign guidelines

›General sepsis resuscitation and antimicrobial timing; cross-referenced rather than duplicated in this topic

›Key clinical studies

›Dindo D et al. Classification of surgical complications

›Annals of Surgery 2004

›Clavien-Dindo grading system for surgical complication severity

›Cohort studies on esophagectomy anastomotic leak outcomes

›Multiple international series reporting leak incidence and mortality by conduit and anastomotic technique

›Cohort studies on risk factors for colorectal anastomotic leak

›Smoking, malnutrition, steroid use, radiotherapy, and emergency surgery consistently identified as independent risk factors

Coding reference

›ICD-10 and related coding

›ICD-10 K91.83 complications of internal anastomosis, not elsewhere classified (anastomotic leak coded here in the absence of a more specific code)

›ICD-10 K65.1 peritoneal abscess (used for postprocedural intra-abdominal abscess)

›ICD-10 K91.89 other postprocedural digestive system complication

›ICD-10 K75.1 phlebitis and thrombophlebitis of portal vein (pylephlebitis)

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed September 13, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.